CasLoc logo
All Cases PTAB Litigations UPC Oppositions

AYLA PHARMA LLC vs. Novartis AG et al.

Explore the PTAB proceeding IPR2020-00295 filed by AYLA PHARMA LLC on 2019-12-24. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2020-00295

Filing Date

2019-12-24

Accorded Filing Date

2019-12-24

Institution Decision Date

2020-08-06

Last Modified Date

2022-10-10

Proceeding Type

IPR

Termination Date

โ€”

Trial Status

Institution Denied

Parties & Counsel

Petitioner

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 14304124
Respondent Patent Number 9533053
Legal Expiration Date
2032-09-12 Active (5.8 yrs remaining)
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor Daniel A. Gamache et al
Respondent Tech Center TC 1600 (Biotechnology & Organic Chemistry)

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 (Biotechnology & Organic Chemistry)

Decisions Rendered

0 Total

Proceeding Status

Institution Denied

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Address and Attorney/Agent Information

32 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name ALCON INC. - C/O ALCON RESEARCH LLC
Customer Number 26356
Address 6201 SOUTH FREEWAY, TB4-8, FORT WORTH, TX, 76134, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
39030 Jean Silveri +1 617-871-5134
40232 Timothy Witkowski +1 617-301-1869
43228 Peter Waibel +1 862-778-7838
46473 Emily Wu +1 858-812-1539
46593 Laurie Lawrence +1 617-871-8584
48631 Carol Fang +1 650-467-2901
51681 Mark Flanigan +1 817-615-5080
53504 Daniel Raymond +1 858-812-1617

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts Counterparts in force
๐Ÿ›๏ธ
USPTO PTAB Trials 4 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (4 found):
PTAB: 4
USPTO PTAB Trial 2018-06-05
IPR2018-01021

Cipla Limited v. Alcon Research Ltd.

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2018-06-05
IPR2018-01020

Cipla Limited v. Alcon Research Ltd.

U.S. Continuation Sibling (8791154)
Status: Terminated-Settled
USPTO PTAB Trial 2016-08-18
IPR2016-01640

Apotex, Inc. v. Alcon Research, Ltd.

U.S. Continuation Sibling (8791154)
Status: Terminated-Settled
USPTO PTAB Trial 2016-02-02
IPR2016-00544

Argentum Pharmaceuticals, LLC v. Alcon Research, Ltd.

U.S. Continuation Sibling (8791154)
Status: Terminated-Settled
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

77
16

Notice of Refund Paper

2021-06-15 FILING PARTY: BOARD
15

Petitioner's Request for Refund of IPR Fees REQUEST

2021-06-08 FILING PARTY: PETITIONER
14

Decision Denying Rehearing Request Paper

2021-05-06 FILING PARTY: BOARD
13

Petitioner's Request for Rehearing Paper

2020-09-03 FILING PARTY: PETITIONER
12

Trial Instituted Document Paper

2020-08-06 FILING PARTY: BOARD

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc